Rapamycin Enhances the Anti-Cancer Effect of Dasatinib by Suppressing Src/PI3K/mTOR Pathway in NSCLC Cells

• Bin Chen ,

  Contributed equally to this work with: Bin Chen, Xin Xu, Songwen Zhou

  Affiliations Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai, China, School of Medicine Cancer Institute, Tongji University, Shanghai, China

  ⨯
• Xin Xu ,

  Contributed equally to this work with: Bin Chen, Xin Xu, Songwen Zhou

  Affiliations Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai, China, School of Medicine Cancer Institute, Tongji University, Shanghai, China

  ⨯
• Jie Luo,

  Affiliations Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai, China, School of Medicine Cancer Institute, Tongji University, Shanghai, China

  ⨯
• Heyong Wang,

  Affiliations Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai, China, School of Medicine Cancer Institute, Tongji University, Shanghai, China

  ⨯
• Songwen Zhou

  Contributed equally to this work with: Bin Chen, Xin Xu, Songwen Zhou

  * E-mail: zhou_songwen@126.com

  Affiliations Department of Medical Oncology, Shanghai Pulmonary Hospital, Shanghai, China, School of Medicine Cancer Institute, Tongji University, Shanghai, China

  ⨯